ZHENG Lin, GUO Chen yang, LI Hai liang, et al. Significance of transcatheter arterial chemoembolization combined with sorafenib for the treatment of primary hepatocellular carcinoma[J]. Chinese Journal of Digestive Surgery, 2013, 12(3): 236-237. DOI: 10.3760/cma.j.issn.1673-9752.2013.03.019
Citation:
|
ZHENG Lin, GUO Chen yang, LI Hai liang, et al. Significance of transcatheter arterial chemoembolization combined with sorafenib for the treatment of primary hepatocellular carcinoma[J]. Chinese Journal of Digestive Surgery, 2013, 12(3): 236-237. DOI: 10.3760/cma.j.issn.1673-9752.2013.03.019
|
ZHENG Lin, GUO Chen yang, LI Hai liang, et al. Significance of transcatheter arterial chemoembolization combined with sorafenib for the treatment of primary hepatocellular carcinoma[J]. Chinese Journal of Digestive Surgery, 2013, 12(3): 236-237. DOI: 10.3760/cma.j.issn.1673-9752.2013.03.019
Citation:
|
ZHENG Lin, GUO Chen yang, LI Hai liang, et al. Significance of transcatheter arterial chemoembolization combined with sorafenib for the treatment of primary hepatocellular carcinoma[J]. Chinese Journal of Digestive Surgery, 2013, 12(3): 236-237. DOI: 10.3760/cma.j.issn.1673-9752.2013.03.019
|